Reduced CR1 expression on aged human erythrocytes: immuno-electron microscopic and functional analysis
- PMID: 8114517
- DOI: 10.1016/0047-6374(93)90128-e
Reduced CR1 expression on aged human erythrocytes: immuno-electron microscopic and functional analysis
Abstract
Recognition and clearance of aged human erythrocytes (AE) is a complex process involving immune and non-immune reactions. Complement activation on the surface of AE and deposition of the C3b complement component appear to facilitate this process. Complement receptor type 1 (CR1, CD35) expressed on the surface of human erythrocytes binds to C3b molecules and promotes their inactivation by complement factor I. This may protect the erythrocytes from lysis by complement and by phagocytes. It has been previously reported that aging of human erythrocytes is accompanied by a decrease in the number of CR1 molecules expressed on their surface. Results presented here further support this finding with for the first time a presentation of immune-electron microscopic observation. Haemagglutination and binding assays showed that AE express significantly fewer CR1 (CD35) molecules than young erythrocytes (YE). This is associated in AE with reduced CR1-like factor I co-factor activity and increased deposition in vivo of C3, C4 and properdin as well as increased sensitivity to lysis in vitro by homologous and heterologous complement. Three different immuno-electron microscopical techniques have been used to clearly show the quantitative difference in CR1 (CD35) expression between AE and YE. Finally our results demonstrate that the previously reported clustered arrangement of CR1 (CD35) on human erythrocytes is similar on aged and young erythrocytes.
Similar articles
-
Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).Clin Exp Immunol. 1991 Apr;84(1):9-15. doi: 10.1111/j.1365-2249.1991.tb08116.x. Clin Exp Immunol. 1991. PMID: 1826650 Free PMC article.
-
Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.Eur J Immunol. 1990 Feb;20(2):283-9. doi: 10.1002/eji.1830200209. Eur J Immunol. 1990. PMID: 2138082
-
Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).Clin Exp Immunol. 1992 Mar;87(3):422-8. doi: 10.1111/j.1365-2249.1992.tb03013.x. Clin Exp Immunol. 1992. PMID: 1531948 Free PMC article.
-
Erythrocyte complement receptors.Crit Rev Immunol. 1995;15(2):133-54. doi: 10.1615/critrevimmunol.v15.i2.20. Crit Rev Immunol. 1995. PMID: 8573285 Review.
-
Immune complex clearance by complement receptor type 1 in SLE.Autoimmun Rev. 2008 Dec;8(2):160-4. doi: 10.1016/j.autrev.2008.06.002. Epub 2008 Jul 3. Autoimmun Rev. 2008. PMID: 18602499 Review.
Cited by
-
P. falciparum Invasion and Erythrocyte Aging.Cells. 2024 Feb 12;13(4):334. doi: 10.3390/cells13040334. Cells. 2024. PMID: 38391947 Free PMC article. Review.
-
Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia.Malar J. 2011 Dec 29;10:386. doi: 10.1186/1475-2875-10-386. Malar J. 2011. PMID: 22206234 Free PMC article.
-
Exercise, training and red blood cell turnover.Sports Med. 1995 Jan;19(1):9-31. doi: 10.2165/00007256-199519010-00002. Sports Med. 1995. PMID: 7740249 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous